首页> 外文期刊>Journal of Surgical Research: Clinical and Laboratory Investigation >Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors.
【24h】

Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors.

机译:暴发性肝衰竭大鼠的生物人工肝治疗:对肝脏富集和生长相关转录因子DNA结合活性的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: We earlier described a model of fulminant hepatic failure (FHF) in the rat where partial hepatectomy is combined with induction of right liver lobe necrosis. In FHF rats, lack of regeneration of the residual liver was associated with delayed expression of HGF and HGF receptor c-met and elevated blood HGF and TGF-beta1 levels. We then found that intrasplenic hepatocyte transplantation prolonged survival in FHF rats and triggered hepatocyte proliferation in the native liver. The latter effect was associated with accelerated expression of HGF and c-met mRNA in the liver and lowering of blood HGF and TGF-beta1 levels. In the present study we show that in FHF rats, treatment with a bioartificial liver (BAL) had similar effects. MATERIALS AND METHODS: FHF was induced in inbred Lewis rats and after 4 h, Group 1 rats were subjected to a 4-h whole blood perfusion through the BAL loaded with 3 x 10(8) microcarrier-attached syngeneic hepatocytes, whereas Group 2 control rats were treated with the BAL containing microcarriers only. RESULTS: Compared to sham-BAL-treated rats, the test rats lived longer (28 +/- 5 vs 17 +/- 2 h; P = 0.0005), had better coagulation parameters, maintained higher body core temperature, and showed decreased plasma TGF-beta1 levels. In addition, their liver remnants were HGF positive and showed increased DNA binding of transcription factors engaged in the modulation of hepatocyte proliferation (e.g., STAT3) and liver-specific gene expression (e.g., HNF1, HNF4, C/EBP). CONCLUSIONS: This study demonstrates that hepatocyte-based extracorporeal support not only can provide metabolic support by increasing the available functional liver mass but also is capable of modifying humoral and molecular mechanisms which are responsible for proliferation and organ-specific functions of residual hepatocytes. Copyright 1999 Academic Press.
机译:背景:我们先前描述了大鼠暴发性肝衰竭(FHF)模型,其中部分肝切除术与诱导右肝叶坏死相结合。在FHF大鼠中,残留肝脏再生不足与HGF和HGF受体c-met的表达延迟以及血液中HGF和TGF-beta1水平升高有关。然后,我们发现脾内肝细胞移植可延长FHF大鼠的存活率并触发天然肝脏中肝细胞的增殖。后者的作用与肝脏中HGF和c-met mRNA的加速表达以及血液中HGF和TGF-beta1水平的降低有关。在本研究中,我们表明在FHF大鼠中,用生物人工肝(BAL)进行治疗具有相似的作用。材料与方法:FHF是在近交Lewis大鼠中诱导的,在4 h后,第1组大鼠通过BAL进行4 h全血灌注,BAL装有3 x 10(8)微载体连接的同基因肝细胞,而第2组对照组仅用含微载体的BAL治疗大鼠。结果:与sham-BAL处理的大鼠相比,试验大鼠的寿命更长(28 +/- 5 vs 17 +/- 2 h; P = 0.0005),具有更好的凝血参数,维持了较高的体温,并且血浆减少TGF-beta1水平。另外,它们的肝残余为HGF阳性,并显示参与肝细胞增殖调节(例如STAT3)和肝特异性基因表达(例如HNF1,HNF4,C / EBP)的转录因子的DNA结合增加。结论:这项研究表明,基于肝细胞的体外支持不仅可以通过增加可用的功能肝质量来提供代谢支持,而且还能够修饰体液和分子机制,这些机制负责残余肝细胞的增殖和器官特异性功能。版权所有1999,学术出版社。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号